Chromosome 1p36 Deletion Syndrome
|
0.320 |
Biomarker
|
disease |
BEFREE |
Thus, SKI may contribute to some of the phenotypes common in 1p36 deletion syndrome, and particularly to facial clefting.
|
11731796 |
2002 |
Chromosome 1p36 Deletion Syndrome
|
0.320 |
ChromosomalRearrangement
|
disease |
ORPHANET |
Ski proto-oncogene -/- mice have phenotypes that resemble some of the features observed in patients with 1p36 deletion syndrome.
|
12376748 |
2002 |
Aortic Aneurysm
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the TGF-β repressor SKI cause Shprintzen-Goldberg syndrome with aortic aneurysm.
|
23023332 |
2012 |
Aortic Aneurysm
|
0.310 |
Biomarker
|
disease |
CTD_human |
Mutations in the TGF-β repressor SKI cause Shprintzen-Goldberg syndrome with aortic aneurysm.
|
23023332 |
2012 |
Diastematomyelia
|
0.300 |
Biomarker
|
disease |
CTD_human |
Mice lacking the ski proto-oncogene have defects in neurulation, craniofacial, patterning, and skeletal muscle development.
|
9284043 |
1997 |
Neural Tube Defects
|
0.300 |
Biomarker
|
group |
CTD_human |
Mice lacking the ski proto-oncogene have defects in neurulation, craniofacial, patterning, and skeletal muscle development.
|
9284043 |
1997 |
Neurenteric Cyst
|
0.300 |
Biomarker
|
disease |
CTD_human |
Mice lacking the ski proto-oncogene have defects in neurulation, craniofacial, patterning, and skeletal muscle development.
|
9284043 |
1997 |
Tethered Cord Syndrome
|
0.300 |
Biomarker
|
disease |
CTD_human |
Mice lacking the ski proto-oncogene have defects in neurulation, craniofacial, patterning, and skeletal muscle development.
|
9284043 |
1997 |
Congenital musculoskeletal anomalies
|
0.300 |
Biomarker
|
group |
CTD_human |
Mice lacking the ski proto-oncogene have defects in neurulation, craniofacial, patterning, and skeletal muscle development.
|
9284043 |
1997 |
Iniencephaly
|
0.300 |
Biomarker
|
disease |
CTD_human |
Mice lacking the ski proto-oncogene have defects in neurulation, craniofacial, patterning, and skeletal muscle development.
|
9284043 |
1997 |
Craniorachischisis
|
0.300 |
Biomarker
|
disease |
CTD_human |
Mice lacking the ski proto-oncogene have defects in neurulation, craniofacial, patterning, and skeletal muscle development.
|
9284043 |
1997 |
Exencephaly
|
0.300 |
Biomarker
|
disease |
CTD_human |
Mice lacking the ski proto-oncogene have defects in neurulation, craniofacial, patterning, and skeletal muscle development.
|
9284043 |
1997 |
Spinal Cord Myelodysplasia
|
0.300 |
Biomarker
|
disease |
CTD_human |
Mice lacking the ski proto-oncogene have defects in neurulation, craniofacial, patterning, and skeletal muscle development.
|
9284043 |
1997 |
Craniofacial Abnormalities
|
0.300 |
Biomarker
|
group |
CTD_human |
Mice lacking the ski proto-oncogene have defects in neurulation, craniofacial, patterning, and skeletal muscle development.
|
9284043 |
1997 |
Acrania
|
0.300 |
Biomarker
|
disease |
CTD_human |
Mice lacking the ski proto-oncogene have defects in neurulation, craniofacial, patterning, and skeletal muscle development.
|
9284043 |
1997 |
Schinzel-Giedion syndrome
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Familial thoracic aortic aneurysm and aortic dissection
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Intellectual Disability
|
0.120 |
GeneticVariation
|
group |
BEFREE |
A de novo mutation in DHD domain of SKI causing spina bifida with no craniofacial malformation or intellectual disability.
|
30883014 |
2019 |
Intellectual Disability
|
0.120 |
Biomarker
|
group |
BEFREE |
We found that DNA methylation at birth differentiated ADHD trajectories across multiple genomic locations, including probes annotated to SKI (involved in neural tube development), ZNF544 (previously implicated in ADHD), ST3GAL3 (linked to intellectual disability) and PEX2 (related to perixosomal processes).
|
27217153 |
2017 |
Intellectual Disability
|
0.120 |
Biomarker
|
group |
HPO |
|
|
|
Patent ductus arteriosus
|
0.110 |
Biomarker
|
disease |
BEFREE |
Additionally, the immunohistochemical staining-index (SI) score for SKI was significantly higher in AIP than NP, although there was no significant difference between AIP and PDA.
|
29534839 |
2018 |
Seizures
|
0.110 |
Biomarker
|
phenotype |
BEFREE |
Other genes deleted in a subset of the patients likely play a contributory role in the phenotypes, including GABRD and seizures, PRKCZ and neurologic features, and SKI and dysmorphic and neurologic features.
|
20635359 |
2010 |
Patent ductus arteriosus
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Seizures
|
0.110 |
Biomarker
|
phenotype |
HPO |
|
|
|
Body Height
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |